{"abstract": "The agency said it would examine Epogen, Aranesp and Procrit after a clinical trial suggested that high doses might cause strokes.", "web_url": "https://www.nytimes.com/2010/01/07/business/07fda.html", "snippet": "The agency said it would examine Epogen, Aranesp and Procrit after a clinical trial suggested that high doses might cause strokes.", "lead_paragraph": "The Food and Drug Administration said Wednesday that it would review of the safety of the widely used anemia drugs sold by Amgen and Johnson & Johnson after another clinical trial suggested that high doses of one of the drugs might cause strokes.", "print_section": "B", "print_page": "3", "source": "The New York Times", "multimedia": [], "headline": {"main": "F.D.A. Plans Safety Check of 3 Drugs for Anemia", "kicker": null, "content_kicker": null, "print_headline": "F.D.A. Plans Safety Check Of 3 Drugs For Anemia", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "ANEMIA", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson Inc", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 4, "major": "N"}, {"name": "organizations", "value": "AMGEN INC", "rank": 5, "major": "N"}], "pub_date": "2010-01-07T02:37:58+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/1fb7868a-4a64-5089-969b-54a52b0a20e6", "word_count": 635, "uri": "nyt://article/1fb7868a-4a64-5089-969b-54a52b0a20e6"}